• Mashup Score: 6

    Objectives Macrophage activation syndrome (MAS) is a severe, life-threatening complication of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD). The objective of this study was to confirm the adequacy of an emapalumab dosing regimen in relation to interferon-γ (IFNγ) activity by assessing efficacy and safety. The efficacy outcome was MAS remission by week 8,…

    Tweet Tweets with this article
    • ⚠️ #MAS is a life-threatening complication of #sJIA & #AOSD 🔥 ⚗️ #emapalumab -anti-IFNγ- was administered to 14 pts who had previously failed high-dose #glucocorticoids, with or without #anakinra and/or #ciclosporin 📉 remission in 13/14 pts 👉 Link: https://t.co/L96b8wdXjX https://t.co/kv2K1DwPAh

  • Mashup Score: 14

    Objectives Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe, delayed hypersensitivity reaction (DHR). We observed DRESS to inhibitors of interleukin 1 (IL-1) or IL-6 in a small group of patients with Still’s disease with atypical lung disease. We sought to characterise features of patients with Still’s disease with DRESS compared with drug-tolerant Still’s controls. We…

    Tweet Tweets with this article
    • Macrophage Activation Syndrome (MAS/HLH) is not the only STORM ⛈ to fear in #sJIA and #AOSD. In this case, a genetic factor (HLA-DRB1*15) may help to identify those who are at high risk of DRESS, a different type of cytokine storm! See details below: https://t.co/e14WCWN6Qi

  • Mashup Score: 0

    The FDA has approved Novartis’ Ilaris injection for the treatment of active and adult-onset Still’s disease, according to a press release.“Prior to today’s approval, patients had no FDA-approved treatments for their disease, which can include symptoms such as painful arthritis, fevers and rash,” said Nikolay Nikolov, MD, acting director of the Division of

    Tweet Tweets with this article
    • #FDA approves #Ilaris injection for active and adult-onset #stillsdisease https://t.co/yaZQMGVBLB #SJIA https://t.co/uu3SbWjWXE